Barrington Strategic Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Barrington Strategic Wealth Management Group's PFE Position: Q3 2017 in Review
Barrington Strategic Wealth Management Group reduced its Pfizer (PFE) stake by 1.2% in Q3 2017, selling an estimated $17.1K and leaving 44,894 shares worth $1.52M. The position accounts for 0.77% of the portfolio, ranked #35.
Barrington Strategic Wealth Management Group first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.54M in Q3 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Barrington Strategic Wealth Management Group held 44,894 shares of Pfizer worth $1.52M as of Q3 2017.
- Barrington Strategic Wealth Management Group sold 532 Pfizer shares in Q3 2017, an estimated $17.1K.
- Pfizer made up 0.77% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #35 holding.
- Barrington Strategic Wealth Management Group first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
- Barrington Strategic Wealth Management Group's Pfizer position peaked at $1.54M in Q3 2016.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.